- Home
- VYNE vs HSON Comparison
VYNE vs HSON Comparison
Compare VYNE & HSON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYNE
- HSON
- Stock Information
- Founded
- VYNE 2003
- HSON 1999
- Country
- VYNE United States
- HSON United States
- Employees
- VYNE N/A
- HSON N/A
- Industry
- VYNE Biotechnology: Pharmaceutical Preparations
- HSON Professional Services
- Sector
- VYNE Health Care
- HSON Consumer Discretionary
- Exchange
- VYNE Nasdaq
- HSON Nasdaq
- Market Cap
- VYNE 41.9M
- HSON 40.7M
- IPO Year
- VYNE 2018
- HSON N/A
- Fundamental
- Price
- VYNE $2.32
- HSON $12.82
- Analyst Decision
- VYNE Strong Buy
- HSON
- Analyst Count
- VYNE 2
- HSON 0
- Target Price
- VYNE $6.88
- HSON N/A
- AVG Volume (30 Days)
- VYNE 129.4K
- HSON 2.5K
- Earning Date
- VYNE 02-27-2025
- HSON 03-13-2025
- Dividend Yield
- VYNE N/A
- HSON N/A
- EPS Growth
- VYNE N/A
- HSON N/A
- EPS
- VYNE N/A
- HSON N/A
- Revenue
- VYNE $493,000.00
- HSON $140,427,000.00
- Revenue This Year
- VYNE $28.30
- HSON N/A
- Revenue Next Year
- VYNE N/A
- HSON $8.83
- P/E Ratio
- VYNE N/A
- HSON N/A
- Revenue Growth
- VYNE 39.27
- HSON N/A
- 52 Week Low
- VYNE $1.57
- HSON $11.73
- 52 Week High
- VYNE $4.30
- HSON $19.70
- Technical
- Relative Strength Index (RSI)
- VYNE 36.13
- HSON 44.15
- Support Level
- VYNE $2.34
- HSON $12.61
- Resistance Level
- VYNE $3.00
- HSON $13.65
- Average True Range (ATR)
- VYNE 0.27
- HSON 0.39
- MACD
- VYNE -0.08
- HSON 0.06
- Stochastic Oscillator
- VYNE 8.24
- HSON 38.97
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
About HSON Hudson Global Inc.
Hudson Global Inc provides specialized recruitment and related talent solutions. Its core services include Permanent recruitment, Contracting, Recruitment process outsourcing (RPO) and Talent management solutions. Its Permanent recruitment services leverage the company's consultants. In contracting services, it offers project management, interim management, and professional contract staffing services. RPO services deliver permanent and contracting outsourced recruitment solutions to various companies whereas, Talent management solutions feature services like talent assessment, interview training, executive coaching, employee development and outplacement.